logo
Cutting money for energy efficiency isn't just unwise, it's plain dangerous for vulnerable Arizonans

Cutting money for energy efficiency isn't just unwise, it's plain dangerous for vulnerable Arizonans

Yahoo22-04-2025

Photo via Getty Images
As Arizona's summers grow longer and hotter, keeping cool isn't just about comfort — it's a matter of survival.
Extreme heat is the leading weather-related cause of death in the U.S., with vulnerable populations — including children, outdoor workers, communities of color, and those with chronic conditions like asthma or heart disease — facing the most significant risk.
The health dangers are undeniable. According to the Centers for Disease Control and Prevention, extreme heat can lead to heat exhaustion, heatstroke and even death.
The financial burden extreme heat brings is just as alarming. Higher temperatures lead to higher energy bills. Low-income households in Arizona spend nearly 14% of their annual income on energy costs, compared to just 3% for wealthier families.
For seniors, many of whom rely on fixed incomes from Social Security or pension programs and often live in older, inefficient homes that are expensive to cool and maintain, extreme heat leaves them especially vulnerable.
Not all homes are equipped to handle Arizona's harsh summers. Poor insulation, outdated cooling systems and inefficient windows allow heat to build up indoors, forcing air conditioners to work overtime and driving up costs. For families already struggling to pay their bills, this means making tough choices between running the AC and paying for other essentials.
To help alleviate these struggles, investments made possible by the Inflation Reduction Act (IRA) and the Bipartisan Infrastructure Law (BIL) are improving home energy efficiency and lowering energy costs for families. These federal laws are making it easier to upgrade insulation, improve cooling systems, and reduce energy bills — especially during extreme heat waves.
While this support is critical, many families remain unaware of the resources available or face challenges accessing them. Yet, despite these transformative benefits, President Donald Trump's recent executive orders aim to rescind unspent funds from these critical initiatives, undermining progress at a time when continued investment is urgently needed.
The IRA makes it easier than ever for homeowners and renters alike to improve their homes' energy efficiency while reducing costs. Thanks to its incentives, in 2023 alone, more than 3.4 million American households benefited from $8.4 billion in tax credits for clean energy improvements. In Arizona, over 88,000 families saved a combined $285 million on energy efficiency and clean energy investments.
Through the IRA, Arizona families can make energy-efficient home upgrades with tax credits covering up to 30% of the cost — but these programs won't last forever.
Homeowners who install better insulation, energy-efficient windows, or solar panels can receive up to $3,200 in annual tax credits. In comparison, those who upgrade to a high-efficiency heat pump air conditioner can receive up to $2,000 in credits, saving an average of $500 per year on energy bills. Additional incentives are available for purchasing energy-efficient appliances, with rebates for windows, doors, and home energy audits.
Beyond cost savings, these upgrades create cooler, healthier homes. Improved insulation and energy-efficient cooling systems help maintain safe indoor temperatures, while better air circulation reduces indoor air pollution, which is critical for those with heart and lung conditions.
By investing in efficiency, families can protect their health while lowering their utility costs for years to come.
Arizona's summers will only continue to test the resilience of its residents. While existing programs provide relief, their future remains uncertain, making it crucial to take advantage of available resources before they are gone.
For those considering energy efficiency improvements — installing solar panels, upgrading to energy-efficient appliances, or taking advantage of tax credits — now is the time to act. Every step taken today, no matter how small, can make a difference in staying cool, reducing costs and protecting the health of Arizona families in the face of rising temperatures.
Environmental factors like extreme heat are pressing public health issues requiring urgent action. Investing in energy efficiency and ensuring access to cooling resources isn't just about comfort — it's about protecting the health and well-being of our communities today and for generations to come.
To learn how the Inflation Reduction Act's clean energy programs can improve your family's health and lower energy costs, visit azhpca.org/solutions.
SUPPORT: YOU MAKE OUR WORK POSSIBLE

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Anti-DEI group targets Geisinger College of Health Sciences over program
Anti-DEI group targets Geisinger College of Health Sciences over program

Yahoo

time12 minutes ago

  • Yahoo

Anti-DEI group targets Geisinger College of Health Sciences over program

SCRANTON — A national anti-DEI group has targeted the Geisinger College of Health Sciences with recent filings of discrimination complaints. Virginia-based Do No Harm purported in news releases in March and June that it filed separate complaints with two federal agencies against the college, citing as discriminatory its federally funded Center of Excellence for Diversity and Inclusion and a summer program that aimed to help students from Black, Hispanic or Native American communities that are underrepresented in the medical field transition into medical school. The Do No Harm discrimination complaints come amid President Donald Trump's efforts to dismantle DEI, or diversity, equity and inclusion, programs in the public and private sectors. Trump issued executive orders in the first week of his second term targeting DEI initiatives. 'Geisinger College of Health Sciences did a thorough review of our programs after the presidential executive orders were issued to ensure compliance. The pre-matriculation program referenced in the (Do No Harm) complaint ended in 2024 and is no longer active,' Geisinger CHS said in a statement. Do No Harm is labeled by the Southern Poverty Law Center as an 'anti-LGBTQ+ hate group.' Critics of the SPLC say it's politically biased and its definition of hate group is overly broad. Do No Harm first filed a complaint with the U.S. Department of Health and Human Services on March 19 against Geisinger CHS, according to a news release posted on the Do No Harm website. A member of Do No Harm then filed a similar complaint June 5 with the U.S. Department of Education, because Geisinger 'did not learn its lesson' from the initial complaint filed with HHS, the advocacy organization announced in another news release. The Times-Tribune could not verify that the complaints were filed with both departments, and whether either agency investigated the allegations or took any actions. The U.S. Department of Health and Human Services and the U.S. Department of Education through separate representatives said they do not confirm the existence of complaints. Do No Harm, established in April 2022, claims it has 17,000 members, including doctors, nurses, physicians and concerned citizens, and cites its mission as safeguarding health care from ideological threats. 'Do No Harm seeks to highlight and counteract divisive trends in medicine, such as 'Diversity, Equity and Inclusion' and youth-focused gender ideology,' the organization's website says. According to the SPLC, Do No Harm in 2024 filed eight lawsuits challenging programs such as scholarships and fellowships for marginalized people. 'The group claims that the practice of nonprofit organizations like the American Association of University Women to provide fellowships to students of color and LGBTQ+ students — groups historically underrepresented in academia and medicine — harms patients by requiring medical schools to accept or fund unqualified candidates. According to the group, the case was dismissed 'after AAUW agreed to drop the racial criteria in the fellowship's selection process,'' the SPLC website says. According to the website of Geisinger College of Health Sciences, it is the research and education arm of the Geisinger health system. Established in 2022, the college unifies the Geisinger Commonwealth School of Medicine, Geisinger School of Nursing, Geisinger School of Graduate Education, graduate medical education, Center for Faculty and Professional Development and more. * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Show Caption 1 of 3 Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Expand

New Mexico health officials: Measles sample detected in Roswell wastewater testing
New Mexico health officials: Measles sample detected in Roswell wastewater testing

Yahoo

time26 minutes ago

  • Yahoo

New Mexico health officials: Measles sample detected in Roswell wastewater testing

(Rimma Bondarenko/ Getty Images) New Mexico public health officials on Tuesday announced wastewater testing in Roswell had identified a positive sample for measles. A state health department news release said the June 3 sample result will not impact the number of cases in the state, which requires a diagnosis and often a laboratory confirmation of a sample taken from a person. The sample comes as part of a wastewater testing initiative NMDOH undertook starting in mid-March, conducting weekly wastewater measles testing in Albuquerque/Bernalillo County, Carlsbad, Chaparral, Deming, Las Cruces, Portales, Rincon, Rio Rancho, Roswell, Santa Fe and the South Central treatment plant in Doña Ana County. In an interview with Source NM, NMDOH Medical Epidemiologist Dr. Daniel Sosin said the agency is partnering with researchers at Rice University in Houston Texas for that testing. The wastewater results have limits, and don't reveal when, where or even how many people might have measles. But they do provide warning. In this case, the positive result from Roswell indicates more cases might be coming in Chaves County, NMDOH says. Chaves County 's last measles case was recorded on April 5. As of Tuesday, New Mexico measles infections remain unchanged at 81 cases. Sosin said the wastewater testing program augments the department's strategies for increasing vaccine availability and contract-tracing known cases, and likened the approach to layers of Swiss cheese. 'If you have enough slices, you cover the holes so cases don't slip through,' Sosin said. 'Wastewater is one more layer that helps us monitor for a condition that we don't expect to see in all parts of the state, but could see and want early recognition for.' Sosin said measles wastewater testing is better for early detection or asymptomatic spread, and those detections could mean putting area doctors on alert for additional cases. The major limitation of wastewater surveillance, he said, is the tool is only precise for a general picture and cannot be narrowed further. 'We can't follow up for contact tracing or notifications to reduce ongoing transmission,' Sosin said. 'It's really more of an indicator that [measles] is there and we should be watching more carefully for it.' Sosin said the best guidance to the public remains the recommendation to get two doses of the vaccine to prevent contracting and spreading the measles. The state says since Feb. 1, 34,210 New Mexicans have received MMR shots. Measles symptoms can appear one to three weeks after contact with airborne droplets from an infected person's coughs or sneezes. They include fever, cough, red eyes usually followed by a spotted red rash spreading from the head to the body. Measles can be spread in days before and after symptoms emerge. NMDOH urges any people with symptoms to stay at home and contact the NMDOH Helpline at 1-833-796-8773 for further questions about testing, vaccines or treatment. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue
Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue

Miami Herald

timean hour ago

  • Miami Herald

Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue

Even the Hamburglar didn't see this one coming. Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living with obesity, according to the Centers for Disease Control and Prevention. Don't miss the move: Subscribe to TheStreet's free daily newsletter As obesity rates have risen, so have scientists' efforts to address this serious health issue, which can cause asthma, heart disease, stroke, type 2 diabetes and even some cancers. Early attempts to treat obesity came to the market as early as the 1930s. Amphetamines were the prevalent treatment in the 1940s and 1950s and demand continued into the 1990s. Glucagon-like peptide-1 agonists, which mimic the action of the naturally occurring hormone GLP-1, have been available for about two decades. GLP-1 medications, including Ozempic, Wegovy, Zepbound and Mounjaro, have been used for years to treat Type 2 diabetes, and studies have found that they are also effective at encouraging weight loss. Wegovy and Ozempic are manufactured by Novo Nordisk (NVO) , while Eli Lilly (LLY) makes Zepbound and Mounjaro. Image source:One investment firm says increased use of these medications could have serious implications for two of the biggest names in the fast-food industry: McDonald's (MCD) and Domino's Pizza (DPZ) . The market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, is still new and continuously evolving, Goldman Sachs said in a May 22 report. More Restaurants Beloved Mexican restaurant closing iconic location after 63 yearsMajor restaurant chain quietly closes several locationsIconic restaurant closing its doors after 32 years The investment firm lowered its projections for such medication and now forecasts the global market to reach $95 billion by 2030. That's down from the previous estimate of $130 billion to reflect trends influencing how the drugs are priced, how long patients stay on them, and how patient populations are segmented. Goldman lowered its U.S. market projections to a peak of $70 billion, but the firm sees room for greater penetration in markets outside the U.S. Goldman forecasts a market peak of $50 billion outside the US, compared with $35 billion previously. A survey of more than 50 doctors in the US found that lower doses of anti-obesity medications are working well for a majority of patients and insurance coverage is the most important factor in the decision-making process, Goldman Sachs wrote. "But to be clear, even with this moderated forecast, we see a significant growth opportunity for both existing players as well as new entrants into this market," said Asad Haider, head of the health-care business unit within Goldman Sachs Research. Demand for GPL-1 drugs could dramatically hinder the food and restaurant industries, according to a study from Cornell's SC Johnson College of Business and the data firm Numerator. The report, entitled "The No Hunger Games," found that households with at least one user of GLP-1 drugs reduced its grocery spending by about 6% within six months of starting the drugs. The spending cut was as much as 9% for higher-income households. "We also find an 8.6% decline in spending at fast-food chains, coffee shops and limited-service restaurants," the study said. "Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow." The study warned that common side effects of GLP-1 medications, such as nausea, vomiting and gastrointestinal discomfort, have reportedly led to reduced adherence or discontinued use for some patients. Related: McDonald's analyst grills new stock price target on McCrispy reaction "Moreover, their long-term efficacy and safety remain areas of ongoing investigation," the report said. Redburn Atlantic analyst Chris Luyckx focused on the growing adoption of GLP-1 in recent research reports. Luyckx double-downgraded McDonald's to sell from buy with a price target of $260, down from $319. The analyst expects the GLP-1 weight-loss drugs to suppress consumer appetites and says they present an underappreciated longer-term threat for McDonald's. A 1% drag on sales today "could easily build to 10% or more over time," particularly for restaurant brands skewed toward lower-income consumers, the analyst tells investors in a research note. McDonald's stock was down about 1.3% at last check and is up 18.5% from a year ago. Redburn Atlantic also initiated coverage of Domino's Pizza with a sell rating and $340 price target. Domino's, the world's largest pizza chain, faces the heaviest pressure from adoption of GLP-1 weight loss drugs, with high exposure to dinner occasions and lower-income consumers, the firm said. Redburn Atlantic said the company's organic traffic remains weak, with carry-out far outpacing delivery. Challenged system-sales growth and elevated consensus expectations present downside risk for Domino's, the firm said. McDonald's closed regular trading on June 10 down 1.4% at $300.43. Domino's shares were off 2.7% at $455.49. Related: Fund-management veteran skips emotion in investment strategy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store